martin@psg.ucsf.edu
UCSF’s Dr. Jeff Martin and UCSF colleagues, along with Dr. Edward
Mbidde are seeking a student to take on a high level of responsibility
in implementing a randomized trial in Kampala, Uganda to address the hypothesis
that PI-containing HAART is superior to PI-sparing HAART in promoting
Karposi’s Sarcoma (KS) regression.
The work encompasses the investigation
of HIV, Kaposi’s sarcoma-associated herpesvirus (KSHV) infection,
and KS. The selected student will work side-by-side with Ugandan physicians
treating over 200 people with HIV and managing the day-to-day field work.The
student has the opportunity to observe how antiretroviral drugs impact
patients and s/he can focus his/her research on HIV, KSHV or KS.
A one-year commitment is preferred, and there may be additional opportunities
for a two-month experience.
|
